Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31No description of principal activity2024-04-16false20falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 15651959 2024-04-15 15651959 2024-04-16 2024-12-31 15651959 2023-01-01 2024-04-15 15651959 2024-12-31 15651959 1 2024-04-16 2024-12-31 15651959 d:Director2 2024-04-16 2024-12-31 15651959 e:CurrentFinancialInstruments 2024-12-31 15651959 e:CurrentFinancialInstruments e:WithinOneYear 2024-12-31 15651959 e:ShareCapital 2024-04-16 2024-12-31 15651959 e:ShareCapital 2024-12-31 15651959 e:SharePremium 2024-04-16 2024-12-31 15651959 e:SharePremium 2024-12-31 15651959 e:SharePremium 1 2024-04-16 2024-12-31 15651959 e:OtherMiscellaneousReserve 2024-04-16 2024-12-31 15651959 e:OtherMiscellaneousReserve 2024-12-31 15651959 e:OtherMiscellaneousReserve 1 2024-04-16 2024-12-31 15651959 e:RetainedEarningsAccumulatedLosses 2024-04-16 2024-12-31 15651959 e:RetainedEarningsAccumulatedLosses 2024-12-31 15651959 d:OrdinaryShareClass1 2024-04-16 2024-12-31 15651959 d:OrdinaryShareClass1 2024-12-31 15651959 d:FRS102 2024-04-16 2024-12-31 15651959 d:AuditExempt-NoAccountantsReport 2024-04-16 2024-12-31 15651959 d:FullAccounts 2024-04-16 2024-12-31 15651959 d:PrivateLimitedCompanyLtd 2024-04-16 2024-12-31 15651959 2 2024-04-16 2024-12-31 15651959 6 2024-04-16 2024-12-31 15651959 f:PoundSterling 2024-04-16 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure


Registered number: 15651959












TISV 3 LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

 

TISV 3 LIMITED

CONTENTS



Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 8



 
REGISTERED NUMBER:15651959
TISV 3 LIMITED

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
Note
£

Fixed assets
  

Investments
 4 
16,166,617

Current assets
  

Debtors: amounts falling due within one year
 5 
12,478,006

Cash at bank and in hand
 6 
22,146

  
12,500,152

Creditors: amounts falling due within one year
 7 
(21,863,862)

Net current (liabilities)/assets
  
 
 
(9,363,710)

Total assets less current liabilities
  
6,802,907

  

Net assets
  
6,802,907


Capital and reserves
  

Called up share capital 
  
100,000

Other reserves
  
4,263,135

Profit and loss account
  
2,439,772

Total equity
  
6,802,907


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.



The financial statements were approved and authorised for issue by the board and were signed on its behalf on 30 September 2025.




S L G Watson
Director

The notes on pages 3 to 8 form part of these financial statements.

Page 1

 

TISV 3 LIMITED

STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 DECEMBER 2024


Called up share capital
Share premium account
Other reserves
Profit and loss account
Total equity

£
£
£
£
£


Comprehensive income for the period

Profit for the period
-
-
-
2,439,772
2,439,772
Total comprehensive income for the period
-
-
-
2,439,772
2,439,772

Shares issued during the period
100,000
4,263,135
-
-
4,363,135

Share premium cancellation
-
(4,263,135)
4,263,135
-
-


Total transactions with owners
100,000
-
4,263,135
-
4,363,135


At 31 December 2024
100,000
-
4,263,135
2,439,772
6,802,907

The notes on pages 3 to 8 form part of these financial statements.

On 17 September 2024, the Company fully cancelled the share premium issued to create a distributable other reserve.

Page 2

 

TISV 3 LIMITED

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

1.


General information

TISV 3 Limited is a private company limited by shares incorporated in England and Wales. The address of its registered office is 7th floor Wellington House, 125-130 Strand, London, United Kingdom, WC2R 0AP.
The financial statements are presented in Sterling (£), which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

  
2.2

Other income

Dividends receivable are recognised in profit or loss when the shareholder’s right to receive payment is established, provided that it is probable that the economic benefits will flow to the company and the amount can be measured reliably. Dividend income is presented as “other income” in the statement of profit or loss.


2.3

Financial instruments

The Company has elected to apply Sections 11 and 12 of FRS 102 in respect of financial instruments.

Financial assets and financial liabilities are recognised when the Company becomes party to the contractual provisions of the instrument. 

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities. 
 
The component parts of compound instruments issued by the Company are classified separately as financial liabilities and equity in accordance with the substance of the contractual arrangement. On initial recognition the financial liability component is recorded at its fair value. The fair value of the liability component is estimated using the prevailing market interest rate for a similar instrument without equity features. The equity component is determined by deducting the amount of the liability component from the fair value of the compound instrument as a whole. This is recognised in equity and not subsequently remeasured.
 
The Company’s policies for its major classes of financial assets and financial liabilities are set out below. 

Page 3

 

TISV 3 LIMITED

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)




Financial instruments (continued)

Financial assets
Basic financial assets, including trade and other debtors and cash and bank balances are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest for a similar debt instrument. Financing transactions are those in which payment is deferred beyond normal business terms or is financed at a rate of interest that is not a market rate.

Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price, which excludes transaction costs for those financial assets that are subsequently measured at fair value through profit and loss. 
Such financial assets are subsequently measured at fair value through profit or loss, where they are publicly traded, or fair value can be measured reliably, for example by using a valuation technique. Where fair value cannot be measured reliably, the financial asset is measured at cost less impairment. 
 
Financial liabilities

Basic financial liabilities, including trade and other creditors and loans from fellow group companies, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Financing transactions are those in which payment is deferred beyond normal business terms or is financed at a rate of interest that is not a market rate.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Derivative contracts 
Derivatives contracts, including interest rate swaps and foreign exchange forward contracts, are not basic financial instruments. 
Derivatives contracts are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in interest payable and similar expenses or interest receivable and similar income as appropriate. 
 
Derivative contracts 
The Company enters into floating to fixed interest rate swaps to manage its exposure to cash flow risk on its variable rate debt instruments. These derivatives are measured at fair value at each reporting date. To the extent the hedge is effective, movements in fair value are recognised in other comprehensive income and presented in a separate cash flow hedge reserve. Any ineffectiveness is recognised in the profit and loss account for the year within interest payable and similar expenses.
 
Page 4

 

TISV 3 LIMITED

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)




Financial instruments (continued)

Impairment of financial assets
Financial assets measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the profit and loss account. 

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between the asset's carrying amount and the best estimate of the amount the Company would receive for the asset if it were to be sold at the reporting date. 

For financial assets measured at amortised cost, the impairment loss is measured as the difference between the asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If the financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets and financial liabilities
Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) despite having retained some significant risks and rewards of ownership, control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions. 
 
If a transfer does not result in derecognition because the Company has retained significant risks and rewards of ownership of the transferred asset, the Company continues to recognise the transferred asset in its entirety and recognises a financial liability for the consideration received. The asset and liability are not offset. In subsequent periods, the Company recognises any income on the transferred asset and any expense incurred on the financial liability. 
 
Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

Offsetting of financial assets and financial liabilities
Financial assets and liabilities are offset and the net amount reported in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 5

 

TISV 3 LIMITED

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the period in which they are incurred.

 
2.7

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the profit and loss account for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

 
2.8

Associates and joint ventures

Associates and Joint Ventures are held at cost less impairment.

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. 

 
2.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the period was 2.

Page 6

 

TISV 3 LIMITED

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

4.


Fixed asset investments





Investments in joint venture

£



Cost or valuation


Additions
16,166,617



At 31 December 2024
16,166,617





5.


Debtors

2024
£


Other loans
12,390,242

Loan interest receivable
87,764

12,478,006



6.


Cash and cash equivalents

2024
£

Cash at bank and in hand
22,146



7.


Creditors: Amounts falling due within one year

2024
£

Other loans
21,716,310

Accrued interest
147,552

21,863,862


Other loans are payable to the parent companies, carry interest of 8% and 10%, and are unsecured.

Page 7

 

TISV 3 LIMITED

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

8.


Share capital

2024
£
Issued and fully paid


100,000 Ordinary shares of £1 each
100,000




 
Page 8